Divis Laboratories Limited, together with its subsidiaries, engages in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and internationally. It manufactures various APIs for the generics. The company also offers custom synthesis of API's and intermediates for discovery compounds for other pharma companies; and manufactures building blocks for peptides and nucleotides, carotenoids, and chiral ligands. In addition, it engages in the manufacture of Neutraceutical Pharma products. Divis Laboratories exports its products primarily to North America and Europe.